By Abujah Racheal
OWID is an online scientific publication that focuses on major global issues such as poverty, disease, hunger, climate change and war.
OWID, revealed on Tuesday on its official website.
He added that there was already a large gap between vaccination programs in different countries, with some not yet reporting a single dose.
“Some countries do not provide data on the number of people who have been partially or fully immunized.
“A vaccinated person refers to a person who has received at least one dose of a vaccine, and a fully vaccinated person has received all the required doses of a vaccine,” he says.
According to him, while vaccine doses remain relatively scarce around the world, most countries have focused their early vaccination efforts on priority groups such as clinically vulnerable people; people in their sixties, sixties and over; and frontline workers, such as doctors and nurses.
He said there was a striking rift between the continents as well. Africa has the slowest vaccination rate of any continent, with some countries yet to launch mass vaccination campaigns.
“Less wealthy countries are relying on a vaccine sharing deal called Covax, which aims to deliver two billion doses by the end of the year.
“83% of gunshots worldwide have been administered in high income and upper middle income countries.
“Only 0.2% of the doses were administered in low-income countries”,
He also said some countries may have started administering doses but had yet to report data.
He noted that countries for which no vaccination has been reported have not launched a large-scale vaccination campaign or are not regularly reporting data on the number of doses administered.
“The doses administered are plotted on a logarithmic scale. Most vaccines currently in use require two doses for a patient to be fully immunized.
“In February, the United States Food and Drug Administration cleared a single-dose vaccine from pharmaceutical giant Johnson & Johnson for emergency use in the United States.
“Where each vaccine is used Oxford-AstraZeneca129 countries, Pfizer-BioNTech 87 countries, Sinopharm-Beijing 29 countries, Gamaleya (Sputnik V) 26 countries, Sinopharm-Wuhan two countries, Johnson & Johnson two countries, Bharat Biotech (Covaxin), a country and Vector Institute (EpiVacCorona)one country.
“Only countries that report doses administered are shown. Other countries may have approved vaccines but have not yet administered them, ”said OWID.
Short Link: https://wp.me/pcj2iU-3yZe
- Long work hours increase death risk from heart disease, stroke — WHO, ILO
- Tanzania Helpline Calls For Time For Marriage And Child Abuse
- NYCN commends PAN Chairman’s contribution to youths devt. in Nasarawa
- Clergyman canvasses promotion of peaceful coexistence through effective reporting
- Photo Press Release: Call for Nominations – Rugby Africa Inaugural Media and Photography Award
- Long working hours cause 745,000 deaths – UN study
- Call for Nominations: Rugby Africa Inaugural Media and Photography Award
- NAF reaffirms commitment to protect territorial integrity
- Patriots rally to defeat Rivers Hoopers in Basketball Africa League opening